Completed PHASE4 INTERVENTIONAL NCT00129506

Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion

Sponsor: Ibis Reproductive Health

Interventions methotrexate + misoprostol misoprostol

Updated 6 times since 2017 Last updated: Jun 7, 2018 Started: May 31, 2005 Primary completion: Sep 30, 2005 Completion: Oct 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00129506, this PHASE4 trial focuses on Unwanted Pregnancies and remains completed. Sponsored by Ibis Reproductive Health, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jul 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ibis Reproductive Health
Wiebe, Ellen, M.D.

Data source: Wiebe, Ellen, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada